About: Shorter-Course Whole-Brain Radiotherapy for Brain Metastases in Elderly Patients     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • Purpose: Many patients with brain metastases receive whole-brain radiotherapy (WBRT) alone. Using 10 x 3 Gy in 2 weeks is the standard regimen in most centers. Regarding the extraordinarily poor survival prognosis of elderly patients with multiple brain metastases, a shorter WBRT regimen would be preferable. This study compared 10 x 3 Gy with 5 x 4 Gy in elderly patients (}= 65 years). Methods and Materials: Data from 455 elderly patients who received WBRT alone for brain metastases were retrospectively analyzed. Survival and local (= intracerebral) control of 293 patients receiving 10 x 3 Gy were compared with 162 patients receiving 5 x 4 Gy. Eight additional potential prognostic factors were investigated including age, gender, Karnofsky performance score (KPS), primary tumor, number of brain metastases, interval from tumor diagnosis to WBRT, extracerebral metastases, and recursive partitioning analysis (RPA) class. Results: The 6-month overall survival rates were 29% after 5 x 4 Gy and 21% after 10 x 3 Gy (p = 0.020). The 6-month local control rates were 12% and 10%, respectively (p = 0.32). On multivariate analysis, improved overall survival was associated with KPS }= 70 (p < 0.001), only one to three brain metastases (p = 0.029), no extracerebral metastasis (p = 0.012), and lower RPA class (p < 0.001). Improved local control was associated with KPS }= 70 (p < 0.001), breast cancer (p = 0.029), and lower RPA class (p < 0.001). Conclusions: Shorter-course WBRT with 5 x 4 Gy was not inferior to 10 x 3 Gy with respect to overall survival or local control in elderly patients. 5 x 4 Gy appears preferable for the majority of these patients. (C) 2011 Elsevier Inc.
  • Purpose: Many patients with brain metastases receive whole-brain radiotherapy (WBRT) alone. Using 10 x 3 Gy in 2 weeks is the standard regimen in most centers. Regarding the extraordinarily poor survival prognosis of elderly patients with multiple brain metastases, a shorter WBRT regimen would be preferable. This study compared 10 x 3 Gy with 5 x 4 Gy in elderly patients (}= 65 years). Methods and Materials: Data from 455 elderly patients who received WBRT alone for brain metastases were retrospectively analyzed. Survival and local (= intracerebral) control of 293 patients receiving 10 x 3 Gy were compared with 162 patients receiving 5 x 4 Gy. Eight additional potential prognostic factors were investigated including age, gender, Karnofsky performance score (KPS), primary tumor, number of brain metastases, interval from tumor diagnosis to WBRT, extracerebral metastases, and recursive partitioning analysis (RPA) class. Results: The 6-month overall survival rates were 29% after 5 x 4 Gy and 21% after 10 x 3 Gy (p = 0.020). The 6-month local control rates were 12% and 10%, respectively (p = 0.32). On multivariate analysis, improved overall survival was associated with KPS }= 70 (p < 0.001), only one to three brain metastases (p = 0.029), no extracerebral metastasis (p = 0.012), and lower RPA class (p < 0.001). Improved local control was associated with KPS }= 70 (p < 0.001), breast cancer (p = 0.029), and lower RPA class (p < 0.001). Conclusions: Shorter-course WBRT with 5 x 4 Gy was not inferior to 10 x 3 Gy with respect to overall survival or local control in elderly patients. 5 x 4 Gy appears preferable for the majority of these patients. (C) 2011 Elsevier Inc. (en)
Title
  • Shorter-Course Whole-Brain Radiotherapy for Brain Metastases in Elderly Patients
  • Shorter-Course Whole-Brain Radiotherapy for Brain Metastases in Elderly Patients (en)
skos:prefLabel
  • Shorter-Course Whole-Brain Radiotherapy for Brain Metastases in Elderly Patients
  • Shorter-Course Whole-Brain Radiotherapy for Brain Metastases in Elderly Patients (en)
skos:notation
  • RIV/00216208:11130/11:10294185!RIV15-MSM-11130___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I
http://linked.open...iv/cisloPeriodika
  • 4
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 229152
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11130/11:10294185
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • Local control; Survival; Shorter-course WBRT; Brain metastases; Elderly patients (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • US - Spojené státy americké
http://linked.open...ontrolniKodProRIV
  • [B5A2A11530B2]
http://linked.open...i/riv/nazevZdroje
  • International Journal of Radiation Oncology Biology Physics
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 81
http://linked.open...iv/tvurceVysledku
  • Lohynská, Radka
  • Rades, Dirk
  • Schild, Steven E.
  • Stalpers, Lukas J. A.
  • Veninga, Theo
  • Evers, Jasmin N.
http://linked.open...ain/vavai/riv/wos
  • 000309412300035
issn
  • 0360-3016
number of pages
http://bibframe.org/vocab/doi
  • 10.1016/j.ijrobp.2011.01.058
http://localhost/t...ganizacniJednotka
  • 11130
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software